StockNews.AI
BHC
StockNews.AI
209 days

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19

1. Bausch + Lomb will announce Q4 and full-year 2024 results on February 19, 2025. 2. A conference call and webcast will occur at 8 a.m. ET for discussion. 3. Materials will be available on their Investor Relations website before the call. 4. The company has a diverse portfolio including around 400 eye care products. 5. Bausch + Lomb employs approximately 13,000 people globally.

Earnings
+5.96%Current Return
VS
+0.72%S&P 500
$7.4701/22 07:21 AM EDTEvent Start
$7.91501/23 02:11 PM EDTLatest Updated
3m saved
Insight
Article

FAQ

Why Neutral?

Results announcements typically do not immediately impact stock prices unless surprising.

How important is it?

The earnings report could influence investor sentiment and expectations around BHC's financial performance.

Why Short Term?

Investors may react quickly to earnings reports, affecting short-term price fluctuations.

Related Companies

BLCOBHC
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2024 financial results on Wednesday, February 19, 2025. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the call. Conference Call Details Date: Wednesday, February 19, 2025 Time: 8 a.m. ET Webcast: https://www.webcaster4.com/Webcast/Page/2883/51712 Participant Event Dial-in: +1 (888) 506-0062 (North America) +1 (973) 528-0011 (International) Participant Access Code: 785090 Replay Dial-in: +1 (877) 481-4010 (North America) +1 (919) 882-2331 (International) Replay Passcode: 51712 (replay available until March 5, 2025) About Bausch + Lomb Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on X, LinkedIn, Facebook and Instagram. © 2025 Bausch + Lomb.

Related News